![](/img/cover-not-exists.png)
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours
Eskens, F A L M, Tresca, P, Tosi, D, Van Doorn, L, Fontaine, H, Van der Gaast, A, Veyrat-Follet, C, Oprea, C, Hospitel, M, Dieras, VVolume:
110
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.137
Date:
April, 2014
File:
PDF, 322 KB
english, 2014